Project Chernobyl, Brooklyn, New York, USA
Search for other papers by Valentina M. Drozd in
Google Scholar
PubMed
Search for other papers by Igor Branovan in
Google Scholar
PubMed
Search for other papers by Nikolay Shiglik in
Google Scholar
PubMed
Search for other papers by Johannes Biko in
Google Scholar
PubMed
Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany
Search for other papers by Christoph Reiners in
Google Scholar
PubMed
Introduction During the last 30 years, the incidence of differentiated thyroid cancer (DTC) has steadily increased worldwide, most markedly in France, Italy, the Republic of Korea, Australia, and the USA [ 1 - 8 ]. In the USA, DTC incidence is
Search for other papers by Inês Cosme in
Google Scholar
PubMed
Search for other papers by Ana Figueiredo in
Google Scholar
PubMed
Search for other papers by Sara Pinheiro in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The incidence of thyroid carcinoma (TC) increased over the past 50 years ( 1 , 2 ) mainly due to a disproportionate increase in small papillary TC ( 3 ). In 2020, the GLOBOCAN database reported worldwide 586,000 cases of TC
Search for other papers by Catherine Brophy in
Google Scholar
PubMed
Search for other papers by Rania Mehanna in
Google Scholar
PubMed
Search for other papers by Julie McCarthy in
Google Scholar
PubMed
Search for other papers by Antoinette Tuthill in
Google Scholar
PubMed
Search for other papers by Matthew S. Murphy in
Google Scholar
PubMed
Search for other papers by Patrick Sheahan in
Google Scholar
PubMed
Introduction Thyroid nodules are common, being present by palpation in up to 5% of individuals and by ultrasonography (US) in up to 50% [ 1 ]. While the overwhelming majority are benign, it is estimated that the incidence of cancer in
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Allan Linneberg in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Gitte Ravn-Haren in
Google Scholar
PubMed
Search for other papers by Anja Lykke Madsen in
Google Scholar
PubMed
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Charlotte Cerqueira in
Google Scholar
PubMed
Search for other papers by Anne Krejbjerg in
Google Scholar
PubMed
Search for other papers by Lone Banke Rasmussen in
Google Scholar
PubMed
Search for other papers by Lars Ovesen in
Google Scholar
PubMed
Search for other papers by Hans Perrild in
Google Scholar
PubMed
Department of Internal Medicine, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark
Search for other papers by Lena Bjergved Sigurd in
Google Scholar
PubMed
Search for other papers by Betina Heinsbæk Thuesen in
Google Scholar
PubMed
Search for other papers by Pernille Vejbjerg in
Google Scholar
PubMed
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Torben Jørgensen in
Google Scholar
PubMed
(11.8–12.2 mL, P < 0.001) ( 58 ). Effects on thyroid disorders Hyperthyroidism The laboratory studies found that before IF, in 1997–1998, the incidence of overt hyperthyroidism was 128.5 and 80.1 per 100,000 person-years (PY) in western
Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France
Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France
Search for other papers by Haoiinda Kassim in
Google Scholar
PubMed
Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Search for other papers by Mae Chappe in
Google Scholar
PubMed
Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Search for other papers by Anabel García in
Google Scholar
PubMed
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France
Search for other papers by Enora Clero in
Google Scholar
PubMed
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France
Search for other papers by Stephane Maillard in
Google Scholar
PubMed
Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Introduction Registering the incidence of differentiated thyroid carcinoma (DTC) is highly dependent on the medical practice and, in particular, on organized or opportunistic screening [ 1 ]. Therefore, comparing reported incidences requires
Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed
Frates et al. [ 7 ] the accumulated predicted value of US characteristics and basic clinical features ranged between 3 and 48%. The papillary thyroid microcarcinoma (PTMC) is a papillary thyroid carcinoma with a size of ≤1 cm. The overall incidence of
Search for other papers by Lan Wu in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Chen-Yang Feng in
Google Scholar
PubMed
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Yu Chen in
Google Scholar
PubMed
Search for other papers by Wei-Wei Liu in
Google Scholar
PubMed
Search for other papers by Miao-Bian Liang in
Google Scholar
PubMed
Search for other papers by Zike Zhang in
Google Scholar
PubMed
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Su-Mei Cao in
Google Scholar
PubMed
Search for other papers by Mengmeng Li in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer in the endocrine system, and its incidence rates have increased rapidly worldwide over the past decades, with relatively stable or declining mortality rates ( 1 , 2 ). The diverging gap
Search for other papers by L.A. Jonker in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C.A. Lebbink in
Google Scholar
PubMed
Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by M.C.J. Jongmans in
Google Scholar
PubMed
Department of Pediatric Radiology and Nuclear Medicine, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by R.A.J. Nievelstein in
Google Scholar
PubMed
Search for other papers by J.H.M. Merks in
Google Scholar
PubMed
Search for other papers by E.J.M. Nieveen van Dijkum in
Google Scholar
PubMed
Search for other papers by T.P. Links in
Google Scholar
PubMed
Search for other papers by N. Hoogerbrugge in
Google Scholar
PubMed
Search for other papers by A.S.P. van Trotsenburg in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H.M. van Santen in
Google Scholar
PubMed
any childhood cancer may be justified when its incidence reaches 5%, also for tumors with a good prognosis [ 8 , 9 ]. For this reason, the first question that needs to be answered is about the incidence of DTC in children with PHTS. The second
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
most frequent toxicities recorded during both clinical trials and real-life (RL) studies and has a high incidence during LEN treatment (reviewed in Table 1 ). Indeed, in the LEN registration trial SELECT, it was recorded in 67.8% of cases, and 41.8% of
Search for other papers by Dillwyn Williams in
Google Scholar
PubMed
areas needs to be considered: the age-specific incidence of thyroid malignancy, the age-related sensitivity to radiation-induced thyroid cancer, the molecular findings in malignancy, the cell of origin of thyroid carcinomas, and the growth pattern of the